Clinical trial
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in…
NCT00182715 · Velindre NHS Trust, Other · Unknown status
Key facts
| NCT number | NCT00182715 |
|---|---|
| Title | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Three-Arm Randomised Controlled Trial Comparing Either Continuous Chemotherapy Plus Cetuximab or Intermittent Chemotherapy With Standard Continuous Palliative Combination Chemotherapy With Oxaliplatin and a Fluoropyrimidine in First Line Treatment of Metastatic Colorectal Cancer (COIN) |
| Lead sponsor | Velindre NHS Trust, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | cetuximab, capecitabine, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 2,421 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 17, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: